Brind.

The iSpecimen platform ensures regulatory compliance for biospecimens, with the FDA involved.

1 report, 1 independent Updated Aug 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The iSpecimen platform ensures regulatory compliance for biospecimens, with the FDA involved.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ACCESS NewswireiSpecimen's $6M Valuation Doesn't Reflect the Business-Let Alone the $200M Treasury (NASDAQ: ISPC) WOBURN, MA / ACCESS Newswire / August 20, 2025 / A share price of $1.11. A $6.1 million market cap.